Navigation Links
QB3 to Collaborate with Johnson & Johnson Innovation on New Incubator

SAN FRANCISCO, June 5, 2013 /PRNewswire-USNewswire/ -- The California Institute for Quantitative Biosciences (QB3) has signed an agreement with Johnson & Johnson Innovation to allocate 5,000 square feet of the space in QB3's new 24,000-square foot biosciences incubator in San Francisco to launch Janssen Labs @QB3.

Under the collaboration, Johnson & Johnson will have an exclusive agreement to create a Janssen Labs facility within the new incubator at 953 Indiana St., near the UC San Francisco (UCSF) campus at Mission Bay, with an option to expand.

The new space, known as QB3@953, is the fifth and largest incubator launched by the state institute and central to QB3's mission to help build the state's bioeconomy by giving startups the tools they need to succeed. By working with Johnson & Johnson's new California Innovation Center in Menlo Park and with Janssen Labs , QB3 hopes to connect startups to partners that can boost their success.  

"Connecting biotech startups to experts in multiple areas of the bioscience industry is critical in helping entrepreneurs launch viable companies," said QB3 Associate Director Douglas Crawford . "This collaboration can help expand QB3's network of entrepreneurs, while also bridging the gap for many technologies that would not otherwise have a chance to develop."

The agreement marks the first geographical expansion of Janssen Labs, a San Diego life-science incubator that is currently home to 29 companies.  Janssen Labs @QB3 will have a similar open-innovation approach to the San Diego labs, in which entrepreneurs have the benefit of the insights of a major healthcare company, with no strings attached.  Johnson & Johnson affiliates will identify innovators who are developing promising science to address important unmet medical needs.

Companies in Janssen Labs @QB3 will have access to QB3's resources, which include legal and business advisors, assistance in grant writing for federal Small Business Innovation Research funds, and access to high-end equipment and technology in UCSF facilities.

"The partnership is about lifting up courageous scientists who are out there on the edge of discovery, without compromising their intellectual property," Crawford said. "Our hope is that this support will greatly increase the chances of these companies having an impact on both our economy and our health."

The QB3 system also includes two facilities on and adjacent to the UCSF Mission Bay campus, and two others in Berkeley. QB3 is leasing the new space through Dewey Land Co. and will sublease it directly to entrepreneurs.

Ultimately, the new incubator aims to house 20 to 30 new startup companies. Those startups will lease space as at the other QB3 incubators: in amounts as small as a single research bench, making state-of-the-art laboratory space affordable to fledgling operations. QB3@953 will be open to life science startups from both within the University of California and from the outside.

About QB3
QB3 is a cooperative effort among private industry and more than 220 scientists at UC San Francisco, UC Berkeley and UC Santa Cruz. One of four technology institutes created in 2000 by former California Governor Gray Davis , QB3 has a joint mission of supporting science, driving the California economy and transforming scientific research into public good.

Fundamental to the latter two missions are QB3's efforts to commercialize University of California science by creating mutually beneficial partnerships with industry and supporting innovative entrepreneurs. The effort has led to 54 bioscience startup companies currently in QB3's incubator network. QB3 also operates Mission Bay Capital, an $11.3M seed-stage venture capital fund designed to support UC startups. For more information on QB3, visit

SOURCE California Institute for Quantitative Biosciences (QB3)
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Freeslate Collaborates with Medicines for Malaria Venture to Advance Therapeutic for Treating Malaria
2. DuPont Tate & Lyle Bio Products Collaborates with RML Incorporated to Develop Bio-Based Solution for Personal Care Products
3. Research Foundations Collaborate To Fund Phase 1 Study Of Cancer Drug In Alzheimers Disease Patients
4. Sigma Life Science and the Culture Collections of Public Health England Collaborate to Distribute Cells and Cellular Extracts
5. DuPont Collaborates with Agricultural Educators to Reach More Students
6. DuPont Pioneer and Mendel Biotechnology, Inc. Collaborate to Improve Water Use Efficiency and Photosynthesis in Corn
7. Lockheed Martin and Nanyang Technological University to collaborate on nanotechnology
8. Elsevier and Kanazawa University in Japan Collaborate to Map Universitys Research Performance
9. Ceres and Syngenta to Collaborate on Sweet Sorghum Market Development
10. GNS Healthcare, Dana-Farber and Mount Sinai Collaborate to Build Computer Model of Multiple Myeloma
11. Elsevier Collaborates With Infocomm Development Authority of Singapore and Top Academic Institutions to Bring CodeForScience to Singapore
Post Your Comments:
(Date:11/24/2015)... Nov. 24, 2015  Asia-Pacific (APAC) holds the ... (CRO) market. The trend of outsourcing to low-cost ... but higher volume share for the region in ... however, margins in the CRO industry will improve. ... ( ), finds that the market ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... year and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual ... November 2015, where ISPE hosted the largest number of attendees in more than ...
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... the explosion of technology-enabled health and wellness, and the ... book, The Internet of Healthy Things ... or smartphones even existed, Dr. Kvedar, vice president, Connected ... health care delivery, moving care from the hospital or ...
Breaking Biology News(10 mins):